Hualan Biological Vaccine Inc. (SHE:301207)
China · Delayed Price · Currency is CNY 17.22
-0.48 (-2.71%)
Sep 11, 2026, 3:04 PM CST
Hualan Biological Vaccine Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 363.62 | 352.94 | 623.04 | 640.98 | 600.04 | 131.56 |
Short-Term Investments | - | 458.64 | 1,145 | 373.46 | 130 | - |
Trading Asset Securities | 1,788 | 1,973 | 1,458 | 1,599 | 1,419 | 825.82 |
Cash & Short-Term Investments | 2,151 | 2,785 | 3,227 | 2,613 | 2,149 | 957.39 |
Cash Growth | -29.84% | -13.69% | 23.48% | 21.57% | 124.50% | 10.65% |
Accounts Receivable | 900.3 | 1,349 | 1,438 | 1,990 | 1,796 | 1,439 |
Other Receivables | 0.12 | 0.01 | 0.41 | 1.31 | 0.41 | 2.15 |
Receivables | 900.42 | 1,349 | 1,438 | 2,412 | 1,856 | 1,441 |
Inventory | 366.92 | 179.2 | 208.84 | 173.47 | 167.16 | 107.41 |
Other Current Assets | 976.52 | 69.81 | 103.13 | 28.18 | 20.22 | 23.31 |
Total Current Assets | 4,395 | 4,383 | 4,977 | 5,227 | 4,193 | 2,529 |
Property, Plant & Equipment | 873.33 | 943.71 | 1,071 | 1,176 | 1,287 | 1,351 |
Long-Term Investments | - | 1,276 | 1,204 | 1,296 | 1,310 | 356.3 |
Other Intangible Assets | 20.58 | 20.09 | 20.88 | 20.13 | 20.78 | 21.43 |
Long-Term Deferred Tax Assets | 190.05 | 189.06 | 212.73 | 217.97 | 208.56 | 182.9 |
Long-Term Deferred Charges | 27.93 | 27.92 | 27.79 | 27.94 | 28.69 | 33.36 |
Other Long-Term Assets | 772.07 | 4.82 | 11.05 | 30.61 | 27.98 | 48.93 |
Total Assets | 6,279 | 6,844 | 7,523 | 7,995 | 7,076 | 4,523 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 70.28 | 60.98 | 81.78 | 116.76 | 125.67 | 185.5 |
Accrued Expenses | 1.59 | 909.3 | 903.53 | 1,155 | 1,050 | 929.48 |
Short-Term Debt | - | - | 300.18 | 300.18 | 300.18 | 500.44 |
Current Portion of Leases | - | - | - | - | - | 1.03 |
Current Income Taxes Payable | - | - | - | 50.81 | 9.24 | 15.99 |
Current Unearned Revenue | 17.41 | 3.6 | 8.74 | 2.67 | 2.68 | 1.54 |
Other Current Liabilities | 904.1 | 143.14 | 169.9 | 60.63 | 49.13 | 38.19 |
Total Current Liabilities | 993.39 | 1,117 | 1,464 | 1,686 | 1,537 | 1,672 |
Long-Term Leases | - | - | - | - | - | 0.81 |
Long-Term Unearned Revenue | 20.84 | 22.95 | 27.19 | 31.42 | 35.66 | 39.89 |
Long-Term Deferred Tax Liabilities | - | - | 18.8 | 15.22 | 6.41 | 2.5 |
Total Liabilities | 1,014 | 1,140 | 1,510 | 1,732 | 1,579 | 1,715 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 601.03 | 601.03 | 601.03 | 600.02 | 400.01 | 360 |
Additional Paid-In Capital | 2,910 | 2,910 | 2,926 | 2,915 | 3,089 | 879.79 |
Retained Earnings | 1,860 | 2,300 | 2,593 | 2,748 | 2,008 | 1,568 |
Treasury Stock | -106.79 | -106.79 | -106.79 | - | - | - |
Shareholders' Equity | 5,265 | 5,704 | 6,013 | 6,263 | 5,497 | 2,808 |
Total Liabilities & Equity | 6,279 | 6,844 | 7,523 | 7,995 | 7,076 | 4,523 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | - | - | 300.18 | 300.18 | 300.18 | 502.27 |
Net Cash (Debt) | 2,151 | 2,785 | 2,926 | 2,313 | 1,849 | 455.12 |
Net Cash Growth | -29.84% | -4.84% | 26.53% | 25.07% | 306.31% | -31.59% |
Net Cash Per Share | 3.61 | 4.68 | 4.89 | 3.84 | 3.13 | 0.84 |
Filing Date Shares Outstanding | 595.96 | 595 | 595 | 600.02 | 600.02 | 600.02 |
Total Common Shares Outstanding | 595.96 | 595 | 595 | 600.02 | 600.02 | 540 |
Working Capital | 3,402 | 3,266 | 3,512 | 3,541 | 2,656 | 857.07 |
Book Value Per Share | 8.83 | 9.59 | 10.11 | 10.44 | 9.16 | 5.20 |
Tangible Book Value | 5,244 | 5,684 | 5,992 | 6,243 | 5,476 | 2,787 |
Tangible Book Value Per Share | 8.80 | 9.55 | 10.07 | 10.40 | 9.13 | 5.16 |
Buildings | - | 376.55 | 376.55 | 376.55 | 376.19 | 375.5 |
Machinery | - | 1,503 | 1,496 | 1,472 | 1,450 | 1,388 |
Construction In Progress | - | 10.27 | 6.72 | 3.23 | 3.26 | - |